The aim of this article was to investigate the prevalence of overweight and obesity using selected anthropometric variables in a sample of hospitalized coronary heart disease (CHD) patients in Croatia (N=1,298 
Introduction
Overweight and obesity are connected with development of cardiovascular disease (CVD) 1,2 and mortality from CVD 3 . Besides these effects, the presence of obesity includes various health problems (such as sleep disorders, dyspnoea during mild exertion, sweating, social stigmatization and discrimination, etc.) which all reduce the quality of life, increasing the risk of depression 4,5 and shortening one's expected life expectancy for 5-20 years 6 . A special subcategory is central obesity (as measured through waist-to-hip ratio -WHR), since it has additional negative effects on one's health -it increases the risk for cardiometabolic diseases 7 , incidence of cardiovascular events 8 and mortality from cardiovascular and malignant diseases 9 . The results of the famous Framingham Offspring study, in which the body mass index (BMI) was used to determine presence of obesity, have shown that presence of obesity is significant for prediction of occurrence of coronary heart disease (CHD) and cerebrovascular disease 10 .
The World Health Organization (WHO) recommends that men have a waist circumference of up to 102 cm, and women of up to 88 cm 11 , while WHR of >1 for men, and >0.85 for women is considered indicative for obesity 12 . European Society of Cardiology (ESC) Guidelines from 2007 recommend to keep the BMI <25 kg/m 2 and avoidance of central obesity as a measure in primary prevention (it is advised that men with waist circumference 94-102 cm and women with waist circumference 80-88 cm do not increase their weight, while men with waist circumference bigger than 102 cm and women with waist circumference bigger than 88 cm are strongly advised to reduce their body weight) 13, 14 ; in the field of secondary prevention it is recommended in patients which have had a myocardial infarction with ST-segment elevation to reduce their body weight when their BMI is ³30 kg/m 2 and when their waist circumference is >102/88 cm (men/ women) 15 . While all the used measures of overweight and obesity can be confusing, both for the health professional and for the patient, it is reassuring that the 2007 ESC Guidelines explicitly state that there is no single best measure of overweight/obesity and central obesity, and it is possible to use BMI, WHR or just waist circumference when estimating the risk 13, 14 . Croatian Adult Health Survey (CAHS) data from 2003 showed that 38.11% of the surveyed population was overweight (BMI ³25 kg/m 2 ), 20.34% was obese (BMI ³30 kg/m 2 ) and that 43.52% had increased waist circumference. In men the prevalences were 43.2%, 20.1% and 34.98% respectively, while in women they were 33.6%, 20.6% and 51.13%. The authors concluded that as much as 60% of adult population in Croatia was overweight, and as much as 40% was centrally obese 16, 17 . Data were collected by physicians or trained personnel (nurse), coded and entered into the electronic file. Confidentiality of data was ensured in accordance with current applicable codes, declarations and other provisions. The results are shown in tables, and for quantita- Table 1 shows the distribution of subjects according to the value of their BMI. 48.2% of subjects were overweight, and 28.6% were obese, the data was not available for 16 subjects. The data on the measured anthropometric variables (weight, height, BMI, waist circumference, hip circumference, WHR) is shown in 
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Our group presents in this article the available data on the prevalence of overweight, obesity and central obesity among Croatian hospitalized CHD patients. This risk factor is one of interim risk factors for CVD and, although modifiable, represents a more complex type of cardiovascular risk than behavioural risk factors such as smoking or physical inactivity 23 .
There is substantial evidence in currently available literature which shows that presence of overweight and obesity is strongly connected with numerous risk factors for the development of CVD 1,2 and cardiovascular mortality 3 . Severe obesity has been shown to significantly reduce life expectancy for 5-20 years 6 . Some estimates say that at the turn of the century over one billion people were overweight, of which at least 300 million were obese; this supports the broad consensus that today we can truly speak of global epidemic of overweight and obesity 24 . In this context, central obesity plays a critical role, as it bears additional health risks, such as insulin resistance 25 , increased risk for occurrence of cardiometabolic diseases 7 and increased incidence of cardiovascular events 8 ; as it increases mortality both from cardiovascular and malignant diseases 9 . Recently published data suggest that obesity prevalence is increasing worldwide in parallel with type 2 diabetes 26 .
It is no wonder that BMI is frequently used in clinical practice, as it is frequently available from records from everyday clinical practice, modifiable with lifestyle changes and it has been shown that its reduction has favourable effects on other cardiovascular risk factors 27 . Physicians and other health professionals should be encouraged to always record patient weight and height.
When comparing the data from this study with other recent and relevant studies that were also performed in Croatian CHD patient population, comparisons are principally only possible with only one other study which also recorded data on the prevalence of overweight and obesity -the study on European action on secondary prevention by intervention to reduce events (EUROASPIRE III) 28 which was performed in 22 European countries in 2006, one of the countries that participated was also Croatia.
As much as 48.2% of subjects in the surveyed population were only overweight and 28.6% were obese (Table  1 ). There were some statistically significant differences according to sex, men are bigger and heavier than women, they have larger both waist and hip circumference, and WHR when compared to women (Table 3) . When compared to the available data from EUROASPIRE III, where there were 35% of obese CHD patients in the whole European sample and 39% in the Croatian sample 28 , one can see a modest decrease in the prevalence of obesity in this population, which is good news and provides hope that at least some of the preventive measures that have been undertaken seem to be effective in practice. While men seem to be statistically borderline significantly more frequently overweight than women (49.8% vs. 44.4%, p=0.054, c 2 test), this observed statistically borderline significant difference in prevalence of obesity in women (32.8% vs. 26.9% in men, p=0.054, Table 4) in our surveyed population was also observed in EURO-ASPIRE III study, but in that study from 2006 this difference was fully statistically significant (45% in females vs. 32% in males) 28, 29 . Interestingly enough, our findings from the population of Croatian CHD patients seem to mirror those from CAHS from year 2003, where the prevalences of obesity were similar in men and women, but overweight was more frequent in men and central obesity was more frequent in women (over half of female general population was centrally obese!) 16 .
Measurement of WHR as a measure of central obesity has shown that as much as 54.5% of surveyed subjects are centrally obese. Again, comparison with the data from EUROASPIRE III (where central obesity was defined only by measure of waist circumference) on the European level there were 53% of centrally obese patients, while at the same time in the Croatian sample there were 78.8% of CHD patients in this category 28 , so here, like in the case of obesity as measured through BMI, it is not exaggerated to say that findings from our study do give some reassuring data, at least in the field of obesity. However, one should bear in mind that persons with normal BMI, but increased waist circumference have 20% higher risk of dying than persons with normal BMI and waist circumference within normal range as recommended by the WHO (102 cm for men, 88 cm for women) 11 .
Presented data on prevalences of overweight, obesity and central obesity show that although there are some reassuring trends, there is still considerable amount of work to be done if the prevalence of this cardiovascular risk is to be further reduced factor among Croatian CHD patients. While the prevalence of obesity seems to be on the decline, the prevalence of overweight is rising, which may be just an early warning sign of an incoming wave of obesity epidemic in future years. It is only the next studies in this area in the following years that will confirm or dispute this sign. In the meantime, it is imperative that the work on prevention of overweight and obesity continues, so that, hopefully, this cardiovascular risk factor can further be reduced.
PREVALENCIJA PREKOMJERNE TJELESNE TE@INE I PRETILOSTI U HOSPITALIZIRANIH KORONARNIH BOLESNIKA U HRVATSKOJ S A @ E T A K
Cilj ovog rada bio je pokazati prevalenciju prekomjerne tjelesne te`ine i pretilosti uz izabrane antropometrijske varijable na uzorku bolesnika hospitaliziranih zbog koronarne bolesti u Republici Hrvatskoj (N=1,298). Prevalencija prekomjerne tjelesne te`ine i pretilosti u ispitivanoj populaciji bila je visoka: 48,2% ispitanika imalo je prekomjernu tjelesnu te`inu i 28,6% bilo je pretilo (mjerenom putem indeksa tjelesne mase), dok je 54,5% ispitanika bilo centralno pretilo (mjereno putem omjera struk-bokovi). Prikazani podaci o prevalencijama prekomjerne tjelesne te`ine, pretilosti i centralne pretilosti pokazuju da, iako postoje neki ohrabruju}i trendovi, jo{ uvijek je potrebno dosta u~initi kako bi se prevalencija ovog~imbenika rizika za kardiovaskularnu bolest dodatno smanjila kod bolesnika s koronarnom bolesti u Hrvatskoj. Dok se~ini kako se prevalencija pretilosti smanjuje, raste prevalencija prekomjerne tjelesne te`ine, {to bi mogao biti samo rani znak upozorenja nadolaze}eg vala epidemije pretilosti u idu}im godinama.
